期刊文献+

对胶质瘤术后复发及放射性脑损伤鉴别诊断的影像学研究进展 被引量:9

Advances of imaging on differential diagnosis between recurrence of glioma and radiation-induced brain injury
下载PDF
导出
摘要 胶质瘤术后复发及放射治疗所致放射性脑损伤的鉴别诊断是临床面临的一大挑战,两者在临床表现及传统影像学上具有相似的特点,但在组织病理学及治疗措施上却显著不同,因此,运用影像学手段对两者进行鉴别具有重要的临床意义。就扩散加权成像、磁共振波谱、动态对比增强成像、动态磁敏感对比增强成像、正电子发射计算机体层摄影术、单光子发射计算机体层摄影术在鉴别胶质瘤复发和放射性脑损伤中应用的国内外最新研究结果予以综述,以期对临床诊疗提供帮助。 Differentiating recurrence of glioma from radiation-induced brain injury is a central challenge in neurooncology. The 2 very different outcomes after brain tumor treatment often appear similar on traditional imaging studies. They may even manifest with similar clinical symptoms. Distinguishing treatment injury from tumor recurrence is crucial for diagnosis and treatment planning. In this article, we reviewed the latest developments and key findings from research studies exploring the efficacy of structural and functional imaging modalities in differentiating treatment injury from tumor recurrence with DWI, MRS, DCE-MR, DSC-MR, PET, and SPECT. And we discussed the advantages and disadvantages of each approach to provide useful information for making proper diagnosis and treatment planning.
出处 《国际医学放射学杂志》 2013年第3期226-231,共6页 International Journal of Medical Radiology
关键词 胶质瘤复发 放射性脑损伤 扩散加权成像 磁共振波谱 动态对比增强成像 动态磁敏感对比增强成像 正电子发射计算机体层摄影术 单光子发射计算机体层摄影术 Radiation-induced brain injury Recurrence of glioma Diffusion weighted imaging Magnetic resonance spectroscopy Dynamic susceptibility contrast MRI Positron emission tomography Single-photon emission computed tomography
  • 相关文献

参考文献2

二级参考文献21

  • 1Rabinov JD, Lee PL, Barker FG, et al. In vivn 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology, 2002, 225: 871-879.
  • 2Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery, 2002, 51:912-919.
  • 3Preul MC, Leblanc R, Caramanos Z, et al. Magnetic rsonamce spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci, 1998, 25:13-22.
  • 4BShin A, Delattre JY. Complications of radiation therapy on the brain and spinal cord. Semin Neurol, 2004, 24:405-417.
  • 5Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of lowgrade astrocytomas measured by dynamic susceptibility cnntrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy, lnt J Radiat Oncol Biol Phys, 2001, 51: 478-482.
  • 6Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tmnor recurrenee from nonneoplastic contrast-enhancing tissue. AJNR, 2000, 21 : 901-909.
  • 7Xiangsong Z, Weian C. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET. J Neuroonco1,2007,82 : 305-311.
  • 8Tie J, Gunawardana DH, Rosenthal MA. Differentiation of tumor reeun'ence from radiation necrosis in high-grade gliomas using 201T1-SPECT. J Clin Neurosci,2008, 15:1327-1334.
  • 9Langleben DD, Segall GM. PET in diffrentiation of recurrenl brain tumor from radiation injury. J Nuel Med, 2000, 41: 1861-1867.
  • 10Rabinov JD,Lee PL,Barker FG,et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience [J]. Radiology,2002,225(3):871-879.

共引文献28

同被引文献56

  • 1Ruben JD Dally M Bailey M Smith R McLean CA Fedele P.Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy[J].中国神经肿瘤杂志,2006,4(3):221-221. 被引量:17
  • 2Smith G.Sala R,Carroll L. et al. Synthesis and evaluation ofnucleoside radiotracers for imaging proliferation [ J ]. Nucl MedBiol,2012,39(5):652-665.
  • 3Schwarzenberg J, Czemin J, Cloughesy TF. et al. 3'-deoxy^3'- 18F-fluoro-thymidine PET and MRI for early survival predictions in pa-tients with recurrent malignant glioma treated with bevacizumab[J].J Nucl Med,2012,53(1) :29-36.
  • 4Enslow MS, Zollinger LV, Morton KA. et al. Comparison of 18F-flu-oro-deoxyglucose and 18 F-fluorothymidine PET in differentiating ra-diation necrosis from recurrent glioma [J]. Clin nucl med, 2012, 37(9):854-861.
  • 5Gulyas B,Halldin C. New PET radiopharmaceuticals beyond FDGfor brain tumor imag- ing [J], J Nucl Med Mol Imaging,2012,56(2):173-190.
  • 6Hong IK,Kim JH,Ra YS. et al. Diagnostic usefulness of 3'-de-oxy-3;-[18 F] fluorothymi-dine positron emission tomography inrecurrent brain tumor [J], J Comput Assist Tomogr,2011,35(6):679-684.
  • 7Idema A, Hoffmann A,Boogaarts H,et al. 3^Deoxy-S^18F-fluo-rothymidine PET-derived proliferative volume predicts overallsurvival in high-grade glioma patients[J]. J Nucl Med,2012.53(12):1904-1910.
  • 8Aya S,Nobuyuki K. Masaki O. et al. Evaluation of S'-deoxy-S'-[18F] -fluorothymidine (18F-FLT) kinetics correlated with thy-midine kinase-1 expression and cell proliferation in newly diag-nosed gliomas[J]. Euro J Nucl Med and Mol Imaging, 2013, 40(2):175-185.
  • 9Yamamoto Y,Ono Y, Aga F, et al. Correlation of 18F-FLT up-take with tumor grade and Ki-67 immunohistochemistry in pa-tients with newly diagnosed and recurrent gliomas C J 3 . J NuclMed,2012,53(12);1911-1915.
  • 10Hajime S, Nobuyuki K,Keisuke M,et al. Diagnostic value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) positron emis-sion tomography in recurrent high-grade gliomas : Differentiationfrom treatment-induced tissue necrosis[J]. Cancers,2012,4(1) :244-256.

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部